Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older
- People who have been diagnosed with type 2 diabetes (whether recently or some time ago, with or without related health complications, and regardless of their blood sugar control levels), and who are being treated for type 2 diabetes at the endocrinology department of Nice University Hospital — whether as an inpatient, day patient, or outpatient
- People who are able to understand the study information and fill in questionnaires on their own
- People who are enrolled in the French social security system
- People who have not raised an objection to taking part in the study
Who may not be able to join:
- People under 18 years of age
- People who are pregnant
- People with any type of diabetes other than type 2 diabetes (for example, type 1 diabetes, or diabetes caused by another condition or a genetic reason)
- People with haemochromatosis (an iron overload condition)
- People with cystic fibrosis
- People currently being treated with certain medicines that can raise blood sugar levels, including oral corticosteroids, immunosuppressive drugs, dopaminergic agonists, interferon-alpha, or protease inhibitors
- People who have had part or all of their pancreas surgically removed
- People currently undergoing genetic testing to investigate an unusual or unclear type of diabetes
- People who do not speak French
- People with a significant cognitive condition, or a physical or mental disability, that would prevent them from completing the questionnaires
- Adults who are under a legal protection arrangement such as guardianship or curatorship
- People who have refused to participate, or who later withdraw their agreement to participate
- People whose later test results show they have a type of diabetes other than type 2
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Philippe CAROLI-BOSC, Dr, Centre Hospitalier Universitaire de Nice
Phone: +33 4 92 03 21 87
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Prevalence of severe diabetes-related distress (PAID-20 score ≥ 40)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.